中药抗癌治疗:靶向微小RNA调控肿瘤生长与转移的新型抗癌剂
本综述聚焦近六年报道,汇总中药生物活性成分通过调控微小RNA(miRNA)治疗癌症的证据。文章指出miRNA是肿瘤发生、发展和侵袭的关键调控因子,中药天然化合物可作为新型抗癌剂直接抑制肿瘤进展,并强调miRNA调控在中药抗癌治疗及癌症患者诊断中的意义。
要点
- miRNA是肿瘤发生、发展和侵袭的关键调控因子。
- 中药生物活性成分可通过调控miRNA发挥抗癌作用。
- miRNA表达有望作为癌症患者诊断与疗效评估的靶点。
核心结论
- 中药生物活性成分通过调控miRNA抑制肿瘤进展,为中药抗癌治疗提供证据。
研究设计与样本
- 综述,汇总近六年关于中药生物活性成分调控miRNA治疗癌症的报道。
主要发现
- miRNA是肿瘤发生、发展和侵袭的关键调控因子。
- 多种中药天然化合物作为新型抗癌剂可直接抑制肿瘤进展。
- 中药生物活性成分在miRNA调控方面受到广泛关注。
临床怎么用
- 关注miRNA表达作为癌症患者诊断与中药疗效评估的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
MicroRNAs, small non-coding RNA molecules, have gained a reputation of the most substantial regulators in gene network with the ability to down-regulate their targets. Accumulating evidence shifted insight toward microRNAs regulation as the key element of cancer initiation, development, and aggression. Recent studies have attached the importance of traditional Chinese medicine (TCM) to the treatment of various cancers, and the functional natural compounds have been considered as novel anticancer agents to directly inhibit tumor progression. In more recent decades, a wide range of biologically active components of TCM has gained increasing attention to their applications in the modulation of microRNAs. This review is on the purpose of demonstrating the significance of TCM bioactive ingredients in microRNAs regulation for cancer treatment according to the reports mainly in the recent six years, providing the evidence of efficient Chinese herbal medicine-based therapy and effective pro-diagnosis focusing on microRNAs expression of cancer patients.
引用
- Peng F, Xie X, Peng C, et al. Chinese Herbal Medicine-Based Cancer Therapy: Novel Anticancer Agents Targeting MicroRNAs to Regulate Tumor Growth and Metastasis. Am J Chin Med. 2019. PMID: 31801358. doi:10.1142/S0192415X19500873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。